Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database

التفاصيل البيبلوغرافية
العنوان: Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database
المؤلفون: Bonsignore, M. R., Pepin, J. L., Cibella, F., Barbera, C. D., Marrone, O., Verbraecken, J., Saaresranta, T., Basoglu, O. K., Trakada, G., Bouloukaki, I., McNicholas, W. T., Bailly, S., Pataka, A., Kvamme, J. A., Hein, H., Mihaicuta, S., Grote, Ludger, 1964, Fanfulla, F.
المصدر: Frontiers in Neurology. 12
مصطلحات موضوعية: Clinical Medicine, Klinisk medicin, residual sleepness, CPAP adherence, follow-up, Epworth sleepness Scale, sleep duration, sleep latency, wake-active neurons, residual sleepiness, important difference, cpap, use, obesity, scale, Neurosciences & Neurology
الوصف: follow-up visit after 4 months to 2 years. The change in ESS (n = 2,190) was weakly correlated with CPAP use (R2 = 0.023, p 0.0001). Logistic regression showed that an ESS score 10 at the first follow-up visit was associated directly with ESS at baseline and inversely with duration of follow-up, and CPAP use (R2 of the model: 0.417). EDS showed heterogeneity in different European countries both at baseline and at the first follow-up visit, suggesting modulation by cultural and lifestyle factors. In conclusion, residual EDS in CPAP-treated OSA occurred in approximately one in four patients at follow-up; its prevalence was highest (40%) in the first 3 months of treatment and subsequently decreased. The finding of residual EDS in a significant percentage of optimally treated OSA patients suggests that wake-promoting agents may be useful, but their indication should be evaluated after at least 3 months of treatment.
URL الوصول: https://gup.ub.gu.se/publication/307745
قاعدة البيانات: SwePub
الوصف
تدمد:16642295
DOI:10.3389/fneur.2021.690008